title: Executive summary of the consensus document on post-exposure prophylaxis against HIV, HBV and HCV in adults and children.
abstract: Post-exposure prophylaxis (PEP) can be a secondary measure to prevent infection by human immunodeficiency virus (HIV) when primary prevention has failed. PEP is advised for people with sporadic and exceptional risk exposure to HIV. This consensus document about occupational and non-occupational PEP recommendations aims to be a technical document for healthcare professionals. Its main objective is to facilitate the appropriate use of PEP. To this end, some recommendations have been established to assess the risk of transmission in different types of exposure, situations where PEP should be recommended, special circumstances to take into account, antiretroviral (ARV) guidelines including start and end of the treatment, early monitoring of tolerance and adherence to the treatment, subsequent monitoring of people exposed, independently of having received PEP or not, and need of psychological support. This document is intended for all professionals who work in clinical practice in the field of HIV infection.
authors.affiliation: Electronic address: rpolor@msssi.es
authors.forename: Rosa
authors.initials: R
authors.lastname: Polo Rodriguez
authors.forename: Fernando
authors.initials: F
authors.lastname: Lozano
authors.forename: Pedro
authors.initials: P
authors.lastname: González de Castro
authors.forename: Ma Alonso
authors.initials: MA
authors.lastname: Jiménez
authors.forename: Oscar
authors.initials: O
authors.lastname: Miró
authors.forename: Jose
authors.initials: J
authors.lastname: Ramón Blanco
authors.forename: David
authors.initials: D
authors.lastname: Moreno
authors.forename: Carlos
authors.initials: C
authors.lastname: Dueñas
authors.forename: Enriqueta
authors.initials: E
authors.lastname: Muñoz Platón
authors.forename: Marina
authors.initials: M
authors.lastname: Fernández Escribano
authors.forename: Jesús
authors.initials: J
authors.lastname: Sanz Sanz
authors.forename: Carmina
authors.initials: C
authors.lastname: Fumaz
authors.forename: Ignacio
authors.initials: I
authors.lastname: Santos
authors.forename: Federico
authors.initials: F
authors.lastname: García
authors.forename: Ma Jesús
authors.initials: MJ
authors.lastname: Téllez
authors.forename: Raúl
authors.initials: R
authors.lastname: González Montero
authors.forename: Ma Victoria
authors.initials: MV
authors.lastname: Vals Jimenez
authors.forename: Juan  Emilio
authors.initials: J
authors.lastname: Losa
authors.forename: Ma Luisa
authors.initials: ML
authors.lastname: Valle Robles
authors.forename: Jose  Antonio
authors.initials: J
authors.lastname: Iribarren
authors.forename: Enrique
authors.initials: E
authors.lastname: Ortega
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D002648:Child; D015658:HIV Infections / Q000188:drug therapy*; D006509:Hepatitis B / Q000188:drug therapy*; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D016273:Occupational Exposure / Q000517:prevention & control; D056990:Post-Exposure Prophylaxis; D017410:Practice Guidelines as Topic
chemical_list: D019380:Anti-HIV Agents; D000998:Antiviral Agents
keywords: HIV, HBV, HVC; Non-occupational postexposure prophylaxis; Occupational postexposure prophylaxis; Profilaxis postexposición no ocupacional; Profilaxis postexposición ocupacional; VIH, VHB, VHC